Geisinger Launches New Study To Learn More About Sleep And Sleep Disorders

Geisinger has announced it is taking part in a new research study led by the Stanford University School of Medicine. The study, titled Stanford Technology, Analytics, and Genomics in Sleep (STAGES), is designed to provide investigators with more information about sleep and sleep disorders. Geisinger is currently accepting study participants and will enroll more than 11,000 individuals. Other participating medical facilities include The Mayo Clinic and St. Luke’s Hospital in Chesterfield, MO. The study will enroll 30,000 participants in total. Participants in the study must be 13 years old or older and be referred to a Geisinger Sleep Clinic. For additional information or to sign up as a participant of the STAGES study call 570-214-1651.